artenimol has been researched along with Cancer of Prostate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, X; Hou, J; Li, H; Li, Y; Wang, H; Xu, J; Zhang, W; Zhao, D; Zhu, W | 1 |
| Liu, S; Luo, Z; Xia, T; Xu, G; Zhou, S | 1 |
| Kong, J; Li, SS; Liu, L; Ma, Q; Zheng, LJ | 1 |
| Du, SJ; Luo, ZG; Wu, MJ; Xiang, TX; Xu, G; Zou, WQ | 1 |
| Cheng, Y; Ding, X; Jia, X; Jiang, J; Li, Y; Sharma, A; Wang, G; Xie, G | 1 |
| Gallis, B; Goodlett, DR; Gulati, R; Kim, BJ; Morrissey, C; Sasaki, T; Solazzi, JW; Vakar-Lopez, F; Vessella, RL | 1 |
| An, J; Fu, LC; He, Q; Hu, YJ; Huang, Y; Sheikh, MS; Shen, XL; Shi, J; Sun, H; Sun, Q; Wang, L | 1 |
| Ding, GF; Wang, QZ; Wang, XM; Zhang, L | 1 |
8 other study(ies) available for artenimol and Cancer of Prostate
| Article | Year |
|---|---|
Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression.
Topics: Antimalarials; Apoptosis; Artemisinins; Biomarkers, Tumor; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Cells, Cultured | 2019 |
Dihydroartemisinin induces cell apoptosis through repression of UHRF1 in prostate cancer cells.
Topics: Apoptosis; Artemisinins; CCAAT-Enhancer-Binding Proteins; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; Dose-Response Relationship, Drug; Gene Knockdown Techniques; Humans; Male; Prostatic Neoplasms; Ubiquitin-Protein Ligases | 2022 |
Effects of dihydroartemisinin on HSP70 expression in human prostate cancer PC-3 cells.
Topics: Apoptosis; Artemisinins; Cell Survival; Drug Screening Assays, Antitumor; HSP70 Heat-Shock Proteins; Humans; Male; PC-3 Cells; Prostatic Neoplasms | 2019 |
Mechanism of dihydroartemisinin-induced apoptosis in prostate cancer PC3 cells: An iTRAQ-based proteomic analysis.
Topics: Apoptosis; Artemisinins; Cell Line, Tumor; Chromatography, Reverse-Phase; Flow Cytometry; Humans; Male; Microscopy, Electron, Transmission; Prostatic Neoplasms; Proteomics | 2016 |
Application of sequential factorial design and orthogonal array composite design (OACD) to study combination of 5 prostate cancer drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Line, Tumor; Cisplatin; Docetaxel; Doxorubicin; Drug Interactions; Humans; Male; Models, Statistical; Paclitaxel; Prostatic Neoplasms; Regression Analysis; Taxoids | 2017 |
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dimerization; Humans; Iron; Male; Prostatic Neoplasms; Receptors, Transferrin | 2010 |
Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells.
Topics: Apoptosis; Artemisinins; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation; Humans; Male; Models, Biological; Prostatic Neoplasms; Protein Binding; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2010 |
[Inhibitory effect of dihydroartemisinin on the growth of human prostate cancer PC-3M cells and its mechanism].
Topics: Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Vascular Endothelial Growth Factor A | 2012 |